Search Results - Marjolein de Bruin-Weller

Patient-Reported Ocular Disorders and Symptoms in Adults with Moderate-to-Severe Atopic Dermatitis: Screening and Baseline Survey Data from a Clinical Trial by Jonathan Weyne, Andrew Blauvelt, Marjolein de Bruin-Weller, Errol Prens, Penny Asbell, Debra Sierka, Zhen Chen, Brad Shumel

Connect to this object online.

Nomenclature and clinical phenotypes of atopic dermatitis by Giampiero Girolomoni, Marjolein de Bruin-Weller, Valeria Aoki, Kenji Kabashima, Mette Deleuran, Luis Puig, Ashish Bansal, Ana B. Rossi

Connect to this object online.

Economic and Humanistic Burden in Paediatric Patients with Atopic Dermatitis by Roselie Achten, Lisa van der Rijst, Marjanne Piena, Hedda Lamers, Fleur de Beer, Marjolein de Bruin-Weller, Marlies de Graaf

Connect to this object online.

Real-World Treatment Patterns and Treatment Benefits among Adult Patients with Atopic Dermatitis: Results from the Atopic Dermatitis Patient Satisfaction and Unmet Need Survey by Matthias Augustin, Antonio Costanzo, Andrew Pink, Julien Seneschal, Christopher Schuster, Can Mert, Mariana Guerreiro, Nicole Tietz, Susanne Grond, Marjolein de Bruin-Weller

Connect to this object online.

Responder Threshold for Patient-Oriented Eczema Measure (POEM) and Children's Dermatology Life Quality Index (CDLQI) in Adolescents with Atopic Dermatitis by Eric L. Simpson, Marjolein de Bruin-Weller, Laurent Eckert, Diane Whalley, Isabelle Guillemin, Matthew Reaney, Zhen Chen, Lauren Nelson, Shanshan Qin, Ashish Bansal, Abhijit Gadkari

Connect to this object online.

Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment by Lieneke F.M. Ariëns, Kirsten J.M. van Nimwegen, Marjan Shams, Digna T. de Bruin, Jorien van der Schaft, Harmieke van Os-Medendorp, Marjolein De Bruin-Weller

Connect to this object online.

Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations by Melinda J. Gooderham, Marjolein de Bruin-Weller, Stephan Weidinger, Michael J. Cork, Lawrence F. Eichenfield, Eric L. Simpson, Athanasios Tsianakas, Urs Kerkmann, Claire Feeney, William Romero

Connect to this object online.

Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated w... by Shawn G. Kwatra, Marjolein de Bruin-Weller, Jonathan I. Silverberg, Peter Lio, Mette Deleuran, Handan Aydin, Brian M. Calimlim, Michael C. Lane, Yingyi Liu, Sarah Ofori, Stephan Weidinger

Connect to this object online.

Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials by Thomas Bieber, Norito Katoh, Eric L. Simpson, Marjolein de Bruin-Weller, Diamant Thaçi, Antonio Torrelo, Angelina Sontag, Susanne Grond, Maher Issa, Xiaoyu Lu, Tracy Cardillo, Katrin Holzwarth, Jacob P. Thyssen

Connect to this object online.

Treat-to-Target in Atopic Dermatitis: An International Consensus on a Set of Core Decision Points for Systemic Therapies by Marjolein De Bruin-Weller, Tilo Biedermann, Robert Bissonnette, Mette Deleuran, Peter Foley, Giampiero Girolomoni, Jana Hercogová, Chih-Ho Hong, Norito Katoh, Andrew E. Pink, Marie-Aleth Richard, Stephen Shumack, Juan F. Silvestre, Stephan Weidinger

Connect to this object online.

The Treat-to-Target Project in Atopic Dermatitis: One Year On by Marjolein de Bruin-Weller, Mette Deleuran, Tilo Biedermann, Robert Bissonnette, Peter Foley, Giampiero Girolomoni, Jana Hercogová, Chih-Ho Hong, Norito Katoh, Andrew Pink, Marie-Aleth Richard, Stephen Shumack, Juan Francisco Silvestre, Jacob P. Thyssen, Stephan Weidinger

Connect to this object online.

More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic Dermatitis by Andrew Blauvelt, Kilian Eyerich, Alan D. Irvine, Marjolein de Bruin-Weller, Shawn G. Kwatra, Melinda Gooderham, Brian Kim, Brian M. Calimlim, Wan-Ju Lee, Eliza M. Raymundo, Yingyi Liu, Sarah Ofori, Andrew M. Platt, Jonathan I. Silverberg

Connect to this object online.

Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis by Roselie E. Achten, Chantal van Luijk, Lisa van der Rijst, Daphne Bakker, Lotte Spekhorst, Nicolaas Zuithoff, Marie Schuttelaar, Geertruida Romeijn, Angelique Voorberg, Marijke Kamsteeg, Inge Haeck, Marlies de Graaf, Judith Thijs, Joke de Boer, Marjolein de Bruin-Weller

Connect to this object online.

Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index by Lieneke F.M. Ariëns, Abhijit Gadkari, Harmieke van Os-Medendorp, Rajeev Ayyagari, Emi Terasawa, Andreas Kuznik, Zhen Chen, Gaëlle Bégo-Le Bagousse, Yufang Lu, Elena Rizova, Neil M.H. Graham, Gianluca Pirozzi, Marjolein De Bruin-Weller, Laurent Eckert

Connect to this object online.

Lebrikizumab Provides Rapid Clinical Responses Across All Eczema Area and Severity Index Body Regions and Clinical Signs in Adolescents and Adults with Moderate-to-Severe Atopic De... by Eric L. Simpson, Marjolein de Bruin-Weller, H. Chih-ho Hong, Delphine Staumont-Sallé, Andrew Blauvelt, Kilian Eyerich, Melinda Gooderham, Mona Shahriari, Lotus Mallbris, Amber Reck Atwater, Maria Jose Rueda, Yuxin Ding, Zhuqing Liu, Helena Agell, Jonathan I. Silverberg

Connect to this object online.

Management of Ocular Manifestations of Atopic Dermatitis: A Consensus Meeting Using a Modified Delphi Process by Jacob P. Thyssen, Steffen Heegaard, Lena Ivert, Anita Remitz, Tove Agner, Marjolein De Bruin-Weller, Theis Huldt-Nystrøm, Laura Korhonen, Lina U. Ivert, Pekka Leinonen, Johanna Mandelin, Tore Särnhult, Thomas Schopf, Eirik Sundlisæter, Simon F. Thomsen, Thrasyvoulos Tzellos, Christian Vestergaard, Laura von Kobyletzki, Maria Bradley

Connect to this object online.